Translational Therapeutics (United States)

2.1k papers and 94.6k indexed citations i.

About

In recent decades, authors affiliated with Translational Therapeutics (United States) have published 2.1k papers, which have received a total of 94.6k indexed citations. Scholars at this organization have produced 851 papers in Molecular Biology, 251 papers in Immunology and 218 papers in Physiology on the topics of Circadian rhythm and melatonin (98 papers), Inflammatory mediators and NSAID effects (95 papers) and Immune Cell Function and Interaction (74 papers). Their work is cited by papers focused on Molecular Biology (35.4k citations), Immunology (14.0k citations) and Oncology (11.6k citations). Authors at Translational Therapeutics (United States) collaborate with scholars in United States, China and Germany and have published in prestigious journals including Nature, Science and Cell. Some of Translational Therapeutics (United States)'s most productive authors include Garret A. FitzGerald, Daniel J. Rader, Vladimir R. Muzykantov, Emanuela Ricciotti, Wen‐Chao Song, John B. Hogenesch, E. John Wherry, Marcelo G. Kazanietz, Jason Dunkelberger and T.M. Penning.

In The Last Decade

Fields of papers published by authors at Translational Therapeutics (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Translational Therapeutics (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Translational Therapeutics (United States) at the time of their publication.

Countries citing scholars working at Translational Therapeutics (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Translational Therapeutics (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Translational Therapeutics (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Translational Therapeutics (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025